![[PDF] Le cannabis médical, déconfiné et déclassifié : retour sur le récent changement de classification internationale](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/08/psychotropes-28-1-couverture.png?resize=772%2C494&ssl=1)
[PDF] Le cannabis médical, déconfiné et déclassifié : retour sur le récent changement de classification internationale
Accès PDF pour l’article : Riboulet-Zemouli, Kenzi. Psychotropes, vol. 28, no. 1, 2022, pp. 71-104. DOI: 10.3917/psyt.281.0071
Le cannabis médical, déconfiné et déclassifié : retour sur le récent changement de classification internationale
Page officielle de l’article. Riboulet-Zemouli, Kenzi. Psychotropes, vol. 28, no. 1, 2022, pp. 71-104. DOI: 10.3917/psyt.281.0071
Cannabis amnesia – Indian hemp parley at the Office International d’Hygiène Publique in 1935
Authorea Preprints. DOI: 10.22541/au.165237542.24089054/v1
HIGH COMPLIANCE, a lex lata legalization for the non-medical cannabis industry
How to regulate recreational cannabis in accordance with the Single Convention on narcotic drugs, 1961![[PDF] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/03/DHS-paper-cover-KRZ-MK-2022.png?resize=682%2C503&ssl=1)
[PDF] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications
Full PDF access for the article as published in Drugs, Habits and Social Policy, 2022; 23(1): 5-21. DOI: 10.1108/DHS-11-2021-006
WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications
Access to Journal page for:Drugs, Habits and Social Policy, 2022; 23(1): 5-21. DOI: 10.1108/DHS-11-2021-006